Cell Therapeutics (CTIC)

Create an Alert
1.32 +0.07  +5.60%   NASDAQ Jun 18, 4:44PM BATS Real time Currency in USD

Cell Therapeutics Enterprise Value:

110.33M for June 18, 2013
View Full Chart

Cell Therapeutics Enterprise Value Chart

    Cell Therapeutics Historical Enterprise Value Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 82   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    June 18, 2013 110.33M
    June 17, 2013 108.64M
    June 14, 2013 100.76M
    June 13, 2013 101.88M
    June 12, 2013 103.01M
    June 11, 2013 106.39M
    June 10, 2013 105.26M
    June 7, 2013 104.13M
    June 6, 2013 108.64M
    June 5, 2013 107.51M
    June 4, 2013 106.39M
    June 3, 2013 114.27M
    May 31, 2013 106.39M
    May 30, 2013 104.13M
    May 29, 2013 107.51M
    May 28, 2013 106.39M
    May 24, 2013 107.51M
    May 23, 2013 105.26M
    May 22, 2013 113.15M
    May 21, 2013 116.52M
    May 20, 2013 105.26M
    May 17, 2013 98.50M
    May 16, 2013 97.38M
    May 15, 2013 99.63M
    May 14, 2013 101.88M
       
    May 13, 2013 101.88M
    May 10, 2013 100.76M
    May 9, 2013 97.38M
    May 8, 2013 99.63M
    May 7, 2013 101.88M
    May 6, 2013 100.76M
    May 3, 2013 95.12M
    May 2, 2013 99.63M
    May 1, 2013 94.00M
    April 30, 2013 96.25M
    April 29, 2013 99.63M
    April 26, 2013 97.38M
    April 25, 2013 99.64M
    April 24, 2013 92.88M
    April 23, 2013 89.50M
    April 22, 2013 98.51M
    April 19, 2013 89.50M
    April 18, 2013 87.24M
    April 17, 2013 89.50M
    April 16, 2013 91.75M
    April 15, 2013 88.37M
    April 12, 2013 94.00M
    April 11, 2013 98.51M
    April 10, 2013 96.26M
    April 9, 2013 96.26M

    About Enterprise Value

    Click "Learn More" below to see how YCharts calculates Enterprise Value.

    Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

    EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
    Learn More

    Get data for

    CTIC Enterprise Value Benchmarks

    Companies
    Roche 229.60B
    3SBio 232.51M
    Dendreon 938.44M

    CTIC Enterprise Value Rankings

    Overall 69th percentile
    5047 of 16770
    Sector 67th percentile
    456 of 1408 in Healthcare
    Industry 67th percentile
    145 of 453 in Biotechnology

    CTIC Enterprise Value Range, Past 5 Years

    Minimum 66.80M Mar 27 2013
    Maximum 1.096B Jun 1 2009
    Average 299.42M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');